Arqit (ARQQ) insider sold 28,217 shares; 760 planned sale
Rhea-AI Filing Summary
This Form 144 shows a proposed sale of 760 shares of common stock of the issuer on 10/03/2025 through Fidelity Brokerage Services LLC on the NASDAQ, with an aggregate market value of $38,136.57. The 760 shares were acquired by the seller via restricted stock vesting on 10/02/2025 and were issued as compensation. The filing also discloses three prior sales by the same person in the past three months: 2,468 shares on 07/07/2025 for $81,567.89, 25,000 shares on 07/18/2025 for $1,080,075.17, and 749 shares on 10/02/2025 for $32,290.14. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- 760 shares to be sold were acquired via restricted stock vesting, indicating the shares were issued as compensation
Negative
- Insider completed a sale of 25,000 shares on 07/18/2025 for $1,080,075.17, showing significant insider selling activity in the period
Insights
TL;DR: Insider proposes to sell 760 newly vested shares and previously sold 28,217 shares in the past three months.
The filing records a proposed sale of 760 shares acquired by restricted stock vesting on 10/02/2025 and slated to trade on 10/03/2025 via Fidelity. The document also discloses three completed sales totaling 28,217 shares for aggregate gross proceeds of $1,194,933.20. These figures are explicit in the filing and reflect the insider's executed and planned dispositions.
This is an informational disclosure under Rule 144; it does not by itself state any undisclosed company developments. The seller affirms they are not aware of undisclosed material adverse information.
FAQ
What does the ARQQ Form 144 disclose about shares to be sold?
How were the 760 ARQQ shares acquired?
What insider sales in the past three months are reported for ARQQ?
Where will the proposed ARQQ sale be executed?
Does the filer state any undisclosed material information in the Form 144?